Madrigal Pharmaceuticals (MDGL) News Today $342.29 +4.18 (+1.24%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$341.25 -1.04 (-0.30%) As of 08/7/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MDGL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Canaccord Genuity Group Forecasts Strong Price Appreciation for Madrigal Pharmaceuticals (NASDAQ:MDGL) StockAugust 7 at 3:04 PM | marketbeat.comMadrigal Reports $212.8M in Q2 Rezdiffra Sales, Expands Global Pipeline and Secures $500M FinancingAugust 7 at 2:49 AM | msn.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Announces Earnings ResultsAugust 6 at 3:56 PM | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Up Following Earnings BeatAugust 6 at 10:13 AM | marketbeat.comAmerican Assets Investment Management LLC Takes Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 6 at 6:07 AM | marketbeat.comMadrigal jumps as MASH drug Rezdiffra drives massive Q2 beatAugust 6 at 3:01 AM | msn.comMadrigal Pharmaceuticals, Inc. (MDGL) Q2 2025 Earnings Call TranscriptAugust 5 at 6:09 PM | seekingalpha.comMadrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate UpdatesAugust 5 at 7:00 AM | globenewswire.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Sold by J. Safra Sarasin Holding AGAugust 5 at 4:57 AM | marketbeat.comEarned Wealth Advisors LLC Buys Shares of 2,422 Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 4, 2025 | marketbeat.comKazazian Asset Management LLC Sells 4,295 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 3, 2025 | marketbeat.comBlueshift Asset Management LLC Invests $406,000 in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 3, 2025 | marketbeat.com1,969 Shares in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Purchased by Universal Beteiligungs und Servicegesellschaft mbHAugust 3, 2025 | marketbeat.comFederated Hermes Inc. Makes New Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 2, 2025 | marketbeat.comTD Asset Management Inc Sells 4,090 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 2, 2025 | marketbeat.comFirst National Trust Co Grows Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 1, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Acquired by Assetmark Inc.August 1, 2025 | marketbeat.comMadrigal Pharmaceuticals: Rezdiffra Expansion Avenues Shift Focus To Long TermJuly 31, 2025 | seekingalpha.comMadrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group LimitedJuly 31, 2025 | finanznachrichten.deMadrigal signs up to $2 billion deal with China's CSPC to develop liver drugJuly 30, 2025 | reuters.comMadrigal signs potential $2 billion-plus deal with China's CSPC to develop liver drugJuly 30, 2025 | reuters.comMadrigal signs up to $2 billion deal to develop CSPC Pharma's GLP-1 drugJuly 30, 2025 | msn.comMadrigal in-pact with CSPC Pharma for obesity drug licenseJuly 30, 2025 | msn.comSkandinaviska Enskilda Banken AB publ Sells 3,820 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)July 30, 2025 | marketbeat.comMadrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group LimitedJuly 30, 2025 | globenewswire.comMadrigal Pharmaceuticals (MDGL) Projected to Post Earnings on WednesdayJuly 30, 2025 | marketbeat.comFiera Capital Corp Increases Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)July 29, 2025 | marketbeat.comBrokerages Set Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Target Price at $420.63July 29, 2025 | americanbankingnews.comMadrigal (MDGL) Secures $500M to Fuel MASH Pipeline ExpansionJuly 26, 2025 | msn.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Recommendation of "Moderate Buy" by BrokeragesJuly 26, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (MDGL)’s Rezdiffra Hits 51% Liver Stiffness Reduction in Phase 3July 25, 2025 | insidermonkey.comMadrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025July 25, 2025 | globenewswire.comRebecca Taub Sells 1,000 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) StockJuly 23, 2025 | marketbeat.comPaul A. Friedman Sells 1,400 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) StockJuly 23, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Rebecca Taub Sells 1,000 SharesJuly 23, 2025 | insidertrades.comMadrigal Pharmaceuticals Secures $500 Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASHJuly 22, 2025 | globenewswire.comVictory Capital Management Inc. Sells 2,245 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)July 22, 2025 | marketbeat.comInsider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Sells 2,657 Shares of StockJuly 19, 2025 | marketbeat.comInsider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Sells 2,700 Shares of StockJuly 19, 2025 | marketbeat.comPaul A. Friedman Sells 26,176 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) StockJuly 19, 2025 | marketbeat.comRebecca Taub Sells 26,444 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) StockJuly 19, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Sells $931,039.37 in StockJuly 19, 2025 | insidertrades.comMadrigal Pharmaceuticals Hits 80-Plus Relative Strength Rating BenchmarkJuly 18, 2025 | msn.comNew York State Common Retirement Fund Boosts Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)July 18, 2025 | marketbeat.comMadrigal stock jumps as patent protection for MASH treatment extendedJuly 16, 2025 | in.investing.comMadrigal Pharmaceuticals shares surge after extended patent protection for MASH therapyJuly 16, 2025 | msn.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Up - Should You Buy?July 16, 2025 | marketbeat.comMadrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffraâ„¢ (Resmetirom)July 16, 2025 | globenewswire.comEmerald Advisers LLC Has $15.87 Million Stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)July 13, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Purchases 16,582 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)July 12, 2025 | marketbeat.com Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Email Address MDGL Media Mentions By Week MDGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDGL News Sentiment▼1.120.39▲Average Medical News Sentiment MDGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDGL Articles This Week▼208▲MDGL Articles Average Week Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News Today Incyte News Today United Therapeutics News Today Neurocrine Biosciences News Today BioMarin Pharmaceutical News Today Exelixis News Today Exact Sciences News Today Halozyme Therapeutics News Today Ionis Pharmaceuticals News Today Repligen News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDGL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
